MIRA Stock Analysis: Buy, Sell, or Hold?
MIRA - MIRA Pharmaceuticals, Inc. Common Stock
$1.22
-0.02 (-1.61%)
▼
5d:
-8.96%
30d:
-19.21%
90d:
-26.06%
HOLD
LOW Confidence
Last Updated: February 2, 2026
Earnings: Dec 03, 2025
0d
Get Alerted When MIRA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: MIRA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: MIRA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: MIRA is currently trading at $1.22, which is considered oversold relative to its 30-day fair value range of $1.34 to $1.51.
Technical Outlook: Technically, MIRA is showing sideways momentum. The price is currently testing key support at $1.22. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $17.75 (+1331.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MIRA is showing sideways momentum. The price is currently testing key support at $1.22. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $17.75 (+1331.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$1.34 -
$1.51
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1331.5% below Wall St target ($17.75)
- CAUTION: Recommendation downgraded due to -9.0% 5-day decline
Fair Price Analysis
30-Day Fair Range
$1.34 -
$1.51
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$1.22
Resistance Level
$1.49
Current Trend
Sideways
Fundamental Context
Forward P/E (Next Year Est.)
-3.02
Wall Street Target
$17.75
(+1331.5%)
Last updated: February 02, 2026 2:21 PM ET
Data refreshes hourly during market hours. Next update: 3:21 PM
Data refreshes hourly during market hours. Next update: 3:21 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MIRA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LLY
Eli Lilly and Company |
STRONG BUY
29 analysts |
$1146 | 55 HOLD |
|
GILD
Gilead Sciences Inc |
BUY
30 analysts |
$139 | 64 BUY |
|
AMGN
Amgen Inc |
HOLD
32 analysts |
$333 | 69 BUY |
|
ABBV
AbbVie Inc |
BUY
28 analysts |
$245 | 61 BUY |
|
BIIB
Biogen Inc |
HOLD
37 analysts |
$193 | 57 HOLD |
